References
- Curiel T J. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007; 117: 1167–1174
- Liu W, Putnam A L, Xu-Yu Z, Szot G L, Lee M R, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701–1711
- Zheng S G, Wang J, Wang P, Gray J D, Horwitz G A. IL-2 is essential for TGF-β to convert naïve CD4 + CD25− cells to CD25+ FOXP3+ regulatory T cells and for expansion of these cells. J Immunol 2007; 178: 2018–2027
- Curiel T J, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942–949
- Woo E Y, Chu C S, Goletz T J, Schlienger K, Yeh H, Coukos G, et al. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001; 61: 4766–4772
- Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003; 9: 4404–4408
- Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A. CD4 + CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003; 98: 1089–1099
- Beyer M, Kochanek M, Darabi K, Popov A, Jensen M, Endl E, et al. Reduced frequencies and suppressive function of CD4 + CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 2005; 106: 2018–2025
- Schreiber T H, Deyev V V, Rosenblatt J D, Podack E R. Tumor-induced suppression of CTL expansion and subjugation by gp-Ig vaccination. Cancer Res 2009; 69: 20026–20033
- Herishanu Y, Kay S, Rogowski O, Pick M, Naparstek E, Deutsch V R, et al. T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression. Leukemia 2005; 19: 1289–1291
- Porakishvili N, Roschupkina T, Kalber T, Jewell A P, Patterson K, Yong K, et al. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clin Exp Immunol 2001; 126: 29–36
- Vukmanovic-Stejic M, Zhang Y, Cook J E, Fletcher J M, McQuaid A, Masters J E, et al. Human CD4 + CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006; 116: 2423–2433
- Jak M, Mous R, Remmerswaal E BM, Spijker R, Jaspers A, Yagüeet A, et al. Enhanced formation and survival of CD4 + CD25hiFOXP3 + T cells in CLL. Leuk Lymphoma 2009; 50: 788–801